The National Basketball Association (NBA) will open an office in Singapore to expand its existing growth initiatives, which include live games, content distribution, youth development programs, fan events, and retail sales.
The Singapore office will report to NBA Asia managing director Scott Levy, who is located in Hong Kong, along with the league's other outposts in Manila and Mumbai.
According to Levy, Asia-Pacific has proven to be a major growth region for the NBA over the past two decades, and opening an office in Singapore reflects the enormous opportunities to build on that positive momentum.
Over the last three seasons, the NBA League Pass streaming service has seen double-digit subscription growth in Asia-Pacific, and the league claims to have more than 35 million social media followers in the region.
The NBA's 20 media partners, which cover 11 nations and eight languages, distribute NBA games and content. The league has played 17 preseason and regular-season games in the region in recent years.
The NBA also has offices in Beijing, Dakar, Johannesburg, Lagos, London, Madrid, Mexico City, New York/New Jersey, Rio de Janeiro, Shanghai, and Toronto.


Bernstein Picks BYD and Xiaomi as Top China EV Stocks Despite Weaker Demand
FIFA Suspends Balogun Ban, Clears U.S. Striker for Belgium World Cup Clash
Trump’s U.S. Open Visit Delays Final, Fans Face Long Security Lines
Lockheed Martin Secures $153.5 Million in U.S. Defense Contracts
Barclays Warns U.S. Stock Rally May Be Detached From Fundamentals
NAB Q3 Cash Earnings Rise 2% as Lower Credit Charges Boost Profit
European Stocks Edge Higher as Fed Rate Pause Bets Rise
Gold Prices Rise as Weak US Data and Hormuz Risks Boost Safe-Haven Demand
Paramount Skydance Clears Regulatory Hurdles for Warner Bros. Discovery Deal
DOJ Launches Antitrust Investigation Into the NFL Over Broadcast Restrictions
Native American Groups Slam Trump’s Call to Restore Redskins Name
Goldman Sachs Eyes Investors for Nvidia’s $500 Billion AI Financing Plan
Anthropic Revenue Run Rate Hits $65 Billion as IPO Plans Accelerate
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Wall Street Falls as Oil Prices Rise, Fed Minutes and Retail Earnings in Focus
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook 



